Home Contact Center Add this

Debiopharm Academy

Come and meet us

Come and meet our experts, directors & CEOs who will share with you their day-to-day experience of the pharmaceutical industry.

Debiopharm Academy aims to promote constructive conversation between academia and industry, by sharing experiences and understanding of today’s challenges. Each Debiopharm Academy conference covers a specific topic focusing on the operational side of a development drug company such as: personalized medicine, drug manufacturing, new business models, project management, intellectual property or new drug screening.

Launched in September 2013, Debiopharm Academy conferences are intended for university students and professors from both the EPFL and Université de Lausanne (UNIL).

Watch all previous conferences and the highlights on our YouTube Channel!

Follow us on Twitter & have a look at our Facebook page!

pdf Version française


Conferences program

19 November 2015
Nigel McCraken
clock from 17:00 to 19:00
Find on the map
situation EPFL - SV1717A

The Role of Translational Medicine in the Pharmaceutical Industry

Within the pharmaceutical industry we are tasked to provide innovative, differentiated products that will have benefit for both individuals, society and the industry. Currently there is the expectation from both regulatory bodies and payers to better understand the population that will receive benefit as well as provide evidence of additional clinical utility of the drug over either placebo or standard of care. Translational Medicine is one of the disciplines that have evolved over the last number of years to try and address this expectation, with a focus around dose optimization, differentiation, stratification and repositioning.
This lecture will help you understand the role Translational Development plays within the pharmaceutical industry to help translate basic research into clinical utility and the multi-disciplinary tools and highly collaborative approaches that are employed to help deliver a tailored development solution designed to maximize benefit while minimizing risk. Dr Nigel McCracken has worked within the pharmaceutical industry for over 20 years and is a recognized expert in Translational Development with extensive knowledge and understanding in Biomarker Development, Bioinformatics, PKPD, Clinical Pharmacology, DMPK and Clinical Development.

Free registration to our conference


Speaker One Image Nigel McCraken Ph.D.
Vice President,
Translational Medicine,
Debiopharm International